Your Messages Inbox
Your Article Summary
See Latest ArticlesAllos Therapeutics to Hold Post Advisory Committee Conference Call
Allos Therapeutics, 09/02/09
Allos Therapeutics, Inc. announced the Company will hold a webcast conference call on Wednesday, September 2009 to discuss the outcome of the U.S. Food and Drug Administration's Oncologic Drugs Advisory Committee meeting for FOLOTY. FOLOTYN is the Company's investigational selective antifolate that is currently being evaluated by the FDA for the treatment of patients with relapsed or refractory peripheral T–cell lymphoma.
Today in Conferences/Meetings...keeping you current
Receive free subspecialty "5-minute updates" via email
Cytokinetics Announces Non-Clinical Data Relating to GSK-923295 Presented at the 32nd Annual San Antonio Breast Cancer Symposium
Cytokinetics, 12/15/09
Human genome sciences invites investors to listen to webcast of presentation at deutsche bank conference
Human Genome Sciences, 12/14/09
KLAS Ranks PACS Products
HealthDataManagement, 12/11/09
Article Search
Sponsor